Oral aqueous solutions comprising atomoxetine hydrochloride as active ingredient and a liquid carrier comprising xylitol, maltitol and a sweetener which is selected from the group consisting of sucralose, saccharin, sodium or calcium saccharin, stevioside and rebaudioside. The pH of the solution is adjusted to the range of 3.5 to 4.5. The solutions of the present invention are palatable even in the absence of further polyhydric or sugar alcohols, in addition to xylitol and maltitol.
展开▼
